| Title | Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis |
| Abbreviation | Amyloid : int. j. exp. clin. investig. : off. j. Int. Soc. Amyloidosis |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Internal Medicine (Q1); Medicine (miscellaneous) (Q1) |
| h-index | 76 |
| Overall Rank/Ranking | 1262 |
| SCImago Journal Rank (SJR) | 2.146 |
| Impact Score | 5.62 |
| Publisher | Informa Healthcare |
| Country | United Kingdom |
| ISSN | 13506129, 17442818 |
| Best Quartile | Q1 |
| Coverage History | 1994-2025 |
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis is a journal covering the technologies/fields/categories related to Internal Medicine (Q1); Medicine (miscellaneous) (Q1). It is published by Informa Healthcare. The overall rank of Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis is 1262. According to SCImago Journal Rank (SJR), this journal is ranked 2.146. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 76. The best quartile for this journal is Q1.
The ISSN of Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis journal is 13506129, 17442818. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis is cited by a total of 723 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis is 5.62, which is computed in 2025 as per its definition. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis IF is increased by a factor of 1.67 and approximate percentage change is 42.28% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis is 5.62. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 5.62 |
| 2023 | 3.95 |
| 2022 | 4.38 |
| 2021 | 2.34 |
| 2020 | 2.27 |
| 2019 | 1.61 |
| 2018 | 1.87 |
| 2017 | 3.14 |
| 2016 | 2.74 |
| 2015 | 2.24 |
| 2014 | 2.16 |
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis has an h-index of 76. It means 76 articles of this journal have more than 76 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis is 13506129, 17442818. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis is 1262. According to SCImago Journal Rank (SJR), this journal is ranked 2.146. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.146 |
| 2023 | 2.007 |
| 2022 | 1.368 |
| 2021 | 1.706 |
| 2020 | 1.861 |
| 2019 | 1.605 |
| 2018 | 1.970 |
| 2017 | 1.488 |
| 2016 | 1.395 |
| 2015 | 1.401 |
| 2014 | 0.493 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1262 |
| 2023 | 1357 |
| 2022 | 2488 |
| 2021 | 1666 |
| 2020 | 1529 |
| 2019 | 1982 |
| 2018 | 1400 |
| 2017 | 2331 |
| 2016 | 2680 |
| 2015 | 2678 |
| 2014 | 9051 |
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis is published by Informa Healthcare. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1994-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis is Amyloid : int. j. exp. clin. investig. : off. j. Int. Soc. Amyloidosis. This abbreviation ('Amyloid : int. j. exp. clin. investig. : off. j. Int. Soc. Amyloidosis') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Internal Medicine (Q1); Medicine (miscellaneous) (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis latest impact IF is 5.62. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 5.62 (2024) and 1.61 (2019), respectively, in the last 11 years. Moreover, its average IS is 2.94 in the previous 11 years.
The Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis has an SJR (SCImago Journal Rank) of 2.146, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 2.146 in 2024 and the lowest being 0.493 in 2014. Furthermore, the average SJR of the Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis over the previous 11-year period stands at 2.94.
The latest h-index of the Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis is 76.
The Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis is published by the Informa Healthcare, with its country of publication being the United Kingdom.
The Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis is currently ranked 1262 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 1262 in 2024 and its lowest position of 9051 in 2014.
The standard ISO4 abbreviation for the Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis is Amyloid : int. j. exp. clin. investig. : off. j. Int. Soc. Amyloidosis.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis is classified as a journal that the Informa Healthcare publishes.
The Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis is assigned the following International Standard Serial Numbers (ISSN): 13506129, 17442818.
The best quartile for the Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis is Q1 (2024).
The Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis coverage history can be summarized as follows: 1994-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Business Economics and Management | journal | 9811 | Vilnius Gediminas Technical University | 55 | 2.84 |
| Journal of Applied Business Research | journal | 26260 | Clute Institute | 33 | 0.17 |
| Journal of Education and Work | journal | 8987 | Brill Academic Publishers | 47 | 2.08 |
| Syntax | journal | 2676 | Wiley-Blackwell Publishing Ltd | 35 | 1.10 |
| Exploration Geophysics | journal | 18330 | Taylor and Francis Ltd. | 52 | 0.90 |
| Epigenetics | journal | 4304 | Taylor and Francis Ltd. | 117 | 3.37 |
| Archiv fur Geflugelkunde | journal | 28770 | Verlag Eugen Ulmer | 30 | 0.00 |
| SPE International Formation Damage Control Symposium Proceedings | conference and proceedings | 21934 | 16 | 0.00 | |
| Transboundary and Emerging Diseases | journal | 5531 | John Wiley and Sons Ltd | 92 | 3.26 |
| Brazilian Symposium of Computer Graphic and Image Processing | conference and proceedings | 24442 | IEEE Computer Society | 34 | 0.41 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 5.62 |
| 2023 | 3.95 |
| 2022 | 4.38 |
| 2021 | 2.34 |
| 2020 | 2.27 |
| 2019 | 1.61 |
| 2018 | 1.87 |
| 2017 | 3.14 |
| 2016 | 2.74 |
| 2015 | 2.24 |
| 2014 | 2.16 |
